海外の治験の状況「前立腺癌」での検索結果
161件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- PET/MRI in patients with suspected prostate cancer
- Clinical suspected prostate cancer br>MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
- Austria
- 2015-03-04
Not recruiting
- Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Nonmetastatic Castration-resistant Prostate Cancer
- Prostate Cancer Non-Metastatic;Castration-Resistant
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Colombia, Czech Republic, Czechia, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2014-07-22
Not Recruiting
- A clinical trial for advanced prostatic cancer patients . The study medication will be Leuprolide Mesylate, which will be administered as an injection twice. Both the study doctors and clinical trial participants know which treatment is being administered, there will be only one treatment group. The safety and efficacy of the medicinal product will be tested during the study.
- Advanced Prostate Carcinoma MedDRA version: 19.0 Level: LLT Classification code 10036921 Term: Prostate carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Czech Republic, Germany, Lithuania, Poland, Slovakia, Taiwan, United States
- 2014-06-25
Not recruiting
- Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: ENZAMET
- Prostate Cancer
- Australia, Canada, Ireland, New Zealand, United Kingdom, United States of America
- 2014-01-29
Not recruiting
- A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)
- Prostate Neoplasms
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Turkey, Ukraine, United Kingdom
- 2012-10-24
Not Recruiting
- Prospective-randomized and double-blinded trial to evaluate the impact of a peritoneal flap on outcome and postoperative complications after robotic assisted radical prostatectomy (RARP) in patients with localized prostate cancer
- ;C61 - Malignant neoplasm of prostate;I89.8 - Other specified noninfective disorders of lymphatic vessels and lymph nodes
- Austria, Germany
- 2016-12-08
Not recruiting
- Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
- Metastatic Castration-resistant Prostate Cancer
- Argentina, Australia, Austria, Brazil, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Norway, Spain, Sweden, Taiwan, Turkey, United Kingdom, United States
- 2016-11-15
Not Recruiting
- A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone With or Without Lenalidomide in Subjects With Castrate-Resistant Prostate Cancer (CRPC)
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, South Africa, Spain, Sweden, United Kingdom, United States
- 2012-04-30
Not Recruiting
- Efficacy and safety of a new Leuprolide acetate 3.75 mg depot formulation, GP-Pharm s.a., when given as palliative treatment to prostate cancer patients - Leuprolide 3.75 mg
- prostate cancer br>MedDRA version: 6.0 Level: LLT Classification code 10007113
- Austria, Czech Republic, Germany, Hungary, Italy, Spain, United Kingdom
- 2005-10-21
Not Recruiting
- A Multinational Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Russian Federation, Singapore, Slovakia, Spain, Sweden, United Kingdom, United States
- 2013-10-29
